Strategic approaches for early clinical trials in neurodegenerative diseases

Using patient-centric trial design and biomarker insights to support confident development decisions
Generating meaningful clinical insights as early as possible is a growing priority in neurodegenerative disease development. To support faster and more informed decision-making, sponsors are increasingly implementing innovative first-in-human study designs that integrate multiple objectives, streamline development pathways and enable earlier evaluation in patients. These approaches can also help address ethical and tolerability challenges that may limit traditional healthy volunteer studies.
This webinar will explore the opportunities and challenges associated with these strategies, highlighting examples from neurodegenerative disease therapeutics and discuss:
Getting the basics right: Study objectives and population selection
Bringing the patient voice into early development
Biomarkers as decision-making tools in neurodegenerative development
Register for this webinar to learn how early clinical trial design, patient involvement and biomarker strategies can support more informed development decisions in neurodegeneration.

Who Should Attend
The session will benefit clinical researchers, drug development professionals, and scientists involved in early phase clinical trials focused on neurodegenerative diseases. It is particularly intended to raise interest and stimulate innovation in patient engagement strategies, study design optimization, and biomarker selection in first-in-human and early clinical development settings.
Clinical Pharmacologists and Trial Designers working on neurodegenerative disease therapeutics
Medical Scientists and Researchers specializing in CNS disorders and biomarker development
Patient Engagement and Advocacy professionals seeking to improve recruitment and retention in early trials
Regulatory Affairs Specialists interested in strategic biomarker implementation for trial approval
Pharmaceutical and biotech industry professionals involved in early clinical development and feasibility assessments
Clinicians and Translational Researchers focusing on patient-centric trial methodologies and outcomes

What You Will Learn
Attendees will gain insight into:
Optimizing study objectives and patient selection in early clinical trials
Incorporating the patient voice into early development
Using biomarkers to support development decisions
Addressing ethical and tolerability challenges in first-in-human studies

Register free on Xtalks:
https://xtalks.com/webinars/strategic-approaches-for-early-clinical-trials-in-neurodegenerative-diseases/